论文部分内容阅读
为检验抗凝和抗血栓形成疗法对膜增生性肾小球肾炎(MPGN)的效益,作者用华法令(warfarin)和潘生丁治疗一组MPGN患者进行前瞻性试验。 22例MPGN患者中Ⅰ型21例,Ⅱ型1例。初始肌酐清除率<10ml/min和可能发生出血并发症的患者除外。所有患者于研究前6个月均未接受肾脏病
To test the efficacy of anticoagulant and antithrombotic therapy in the treatment of membranoproliferative glomerulonephritis (MPGN), the prospective trial of a group of MPGN patients with warfarin and dipyridamole was conducted. Among the 22 patients with MPGN, 21 were type Ⅰ and 1 type Ⅱ. Initial creatinine clearance <10ml / min and bleeding complications may occur in patients except. All patients did not receive kidney disease 6 months prior to the study